Home › Steatotic Liver Disease › Indiana
Steatotic Liver Disease clinical trials in Indiana
9 studies for Steatotic Liver Disease are looking for participants at sites in Indiana.
Cities in Indiana
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
- Indiana University School of Medicine, Indianapolis
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT05519475A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Indiana University Health University Hospital, Indianapolis
- Gastroenterology Health Partners, New Albany
- Deaconess Clinic- Gateway, Newburgh
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Hammond
- Akero Clinical Study Site, Indianapolis
- Akero Clinical Study Site, South Bend
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 21, 2026 · NCT06528314A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Digestive Research Alliance of Michiana, South Bend
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 9, 2026 · NCT07288138A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Hammond
- 89bio Clinical Study Site, New Albany
- 89bio Clinical Study Site, South Bend
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Hammond
- 89bio Clinical Study Site, New Albany
- 89bio Clinical Study Site, South Bend
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 3, 2026 · NCT06318169A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Indianapolis
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Aug 3, 2026 · NCT06613698Fibrosis Lessens After Metabolic Surgery
- Indiana University, Indianapolis
RecruitingPhase 4Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Jul 31, 2026 · NCT06374875Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- Indiana University Health, Indianapolis
Recruiting
Ages 18 to 75 · All sexes · Updated May 19, 2026 · NCT04054310From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.